Mohamed Meshref M.D, PhD is a Professor of Oncology at Cairo University and Regional Medical Director at Boehringer Ingelheim for India, Middle East, Turkey & Africa…
In Conversation
The MEA region is indisputably becoming a growth hub for Ipsen
Egypt is a very attractive investment destination in terms of hospitals, if the right management can be found. Every year, 2.5 million children are born in…
As long as we stay focused on the mission of bringing the latest innovations to help more and more patients, we can expect our growth within…
We started to build a roadmap with many milestones that we wanted to achieve for this continent. All of this has to be built from the…
The opportunity is huge for the government to bring in a universal health insurance scheme. As the private industry, we need to participate in helping make…
AbbVie’s increased focus on Egypt has been driven by the reforms that have been happening here, including the creation of the Egypt Drug Authority (EDA), the…
At EVA Pharma, we are trying to be a pan-African company and, while we already have a presence in Western Europe and the Middle East, we…
We are looking to bring in about 11 to 13 new innovative products in the upcoming three years, which is very exciting for the country.
Egypt is ... appealing due to its size, healthcare reform, and the new National Health Insurance Program launch. Egypt has the largest population in the Arab…
Egypt as a country is moving at high speed, with lots of new projects and a high demand for innovation, which we need to match as…
Marianne Abou Elkheir – General Manager & Head of Human Pharma, Levant, Iraq, North-East Africa & Sub-Saharan Africa, Boehringer Ingelheim
Across all the countries under my leadership, I am aware of potential challenges that may stand in our way of achieving our goals. This is why…